Categories: Wire Stories

Yiling Pharmaceutical, a Chinese Enterprise Going Global Under Intricate International Situations

SHIJIAZHUANG CITY, China–(BUSINESS WIRE)–In recent years, the advance of traditional Chinese medicine to the world has become a major trend. Acupuncture-moxibustion, massage and traditional Chinese herbal medicine have been recognized by more and more people from different countries and regions. As a pioneer of introducing traditional Chinese medicine to go global, Yiling Pharmaceutical has been committed to the causes of promoting the international exchange and cooperation of traditional Chinese medicine, promoting technologies, drugs and standard of traditional Chinese medicine to the world, and building an internationally famed brand of traditional Chinese medicine; meanwhile, Yiling has also tried to introduce excellent overseas technologies and products into China to give full play to its role as a bridge and link.

When the novel coronavirus pneumonia was seriously spreading in China, Yiling actively participated in the work of preventing and controlling the pandemic and its product Lianhua Qingwen Capsules was recommended for use by The Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia published by Chinese authorities. In addition, Yiling has also shouldered global responsibility as a Chinese enterprise by helping other countries fight against the pandemic. According to census, Yiling has donated through the Red Cross Society of China drugs and funds worth more than RMB 20 Million Yuan at home and abroad including 3.5 Million Yuan of Lianhua Qingwen Capsules to Italy, Thailand, Iraq and other countries, 3 Million Yuan of Lianhua Qingwen Capsules donated to Shanghai Cooperation Organization, 2 Million Yuan cash donated as international humanitarian assistance. Yiling is willing to share its experience of fighting the pandemic and experience of many years� medical research with the world.

Many of Yiling’s products have been well received in the international market. Lianhua Qingwen, its leading product, has recently obtained approval certificates from nearly 20 countries and regions, including the Philippines. According to reports, with the registration No. of THPR-50 in the Philippines, Lianhua Qingwen Capsules is categorized as a traditional plant medicine. At present, consumers in the Philippines can purchase Lianhua Qingwen at the South Star Drug, Watsons and Mercury Drug.

Contacts

First Name: Li

Last Name: Kristy

E-mail:kristyli@chuhaimedia.com.cn
Phone No.: +86 85962566

Alex

Recent Posts

Asahi Kasei starts operation of multi-module hydrogen pilot plant in Kawasaki

Important milestone towards realization of 100 MW-class alkaline-water electrolysis systems TOKYO & NEW YORK &…

15 mins ago

TotalEnergies Takes Action to Give Access to Clean Cooking to 100 Million People in Africa and India

PARIS--(BUSINESS WIRE)--Regulatory News: At the Clean Cooking Summit organized by the International Energy Agency (IEA),…

16 mins ago

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE: 4502/NYSE:TAK) today announced that it will present data…

17 mins ago

Telstra International Boosts Connectivity to Guam With New Regional Network Hub

NEW YORK--(BUSINESS WIRE)--#TelstraInternational--Telstra International, the global arm of leading telecommunications and technology company Telstra, announced…

19 mins ago

WNS Recognized as a ‘Leader’ by NelsonHall for CX Services Transformation

NEW YORK & LONDON & MUMBAI--(BUSINESS WIRE)--$WNS #AI--WNS (Holdings) Limited (NYSE: WNS), a leading provider…

20 mins ago

Cecilia Chang Earns Prestigious Recognition in the Insurance’s “Global 100” Award

HONG KONG SAR - Media OutReach Newswire - 14 May 2024 - Ms. Cecilia Chang,…

21 mins ago